On or around 07/13/2017 (Court's order of dismissal)
Filing Date: January 06, 2017
According to the law firm press release, the complaint filed in this lawsuit alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose: (1) that the Twirla contraceptive patch had an efficacy rating that fell below peer group standards; (2) that over half of patients in its “Secure” Phase 3 Study discontinued the study early; (3) that the Twirla patch therefore allegedly had a slight chance of FDA approval; and (4) that, as a result of the foregoing, Defendants’ statements about Agile’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
Pursuant to a Stipulation by the parties, this case was ordered dismissed on July 13, 2017.
Company & Securities Information
Defendant: Agile Therapeutics, Inc.
Industry: Major Drugs
Headquarters: United States
Ticker Symbol: AGRX
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Bixing Peng, et al. v. Agile Therapeutics, Inc., et al.
Class Action Complaint for Violations of the Federal Securities Laws
Order Granting Motion Of Hoyt W. Clark For Consolidation Of The Actions, Appointment As Lead Plaintiff, And Approval Of Selection Of Counsel; And Setting Briefing Schedule For Amended Pleading And Motion To Dismiss
Stipulation Of Dismissal With Prejudice
U.S. District Court Civil Docket
—Reference Complaint Complaint Related Data is not available
Related District Court Filings
—Related District Court Filings Data is not available